Gilead Sciences (United Kingdom)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United Kingdom), United Kingdom, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
80%
Total
Publications
268
Total Open
Publications
215
Total
Citations
12K
Open Access
Percentage
80%
Total
Publications
268
Total Open
Publications
215
Total
Citations
12K
Breakdown
Publisher Open
35%
Both
29%
Other Platform Open
16%
Closed
20%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
47
Hybrid 41%
70
No Guarantees 32%
55
Other Platform Open
Domain 84%
103
Institution 35%
43
Other Internet 10%
12
Public 6%
7
Preprint 5%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 103 |
Europe PMC | Domain | 54 |
University of Bristol - Bristol Research | Institution | 5 |
Semantic Scholar | Public | 5 |
University of California - eScholarship University of California | Institution | 4 |
Research Square | Preprint | 4 |
California Digital Library - eScholarship | Other Internet | 4 |
University of Nottingham - Repository@Nottingham | Institution | 3 |
University of Dundee - Discovery Research Portal | Institution | 3 |
Universitat Pompeu Fabra - Repositori digital de la UPF | Institution | 3 |